Drug Profile
Research programme: infertility therapeutics - Merck Sharp and Dohme
Alternative Names: ORG 214444; ORG 241549; ORG 33409Latest Information Update: 23 Feb 2015
Price :
$50
*
At a glance
- Originator Organon
- Developer Merck & Co
- Class Dihydropyridines; Follicle stimulating hormones; Gonadotropins; Recombinant proteins
- Mechanism of Action Ovarian follicle stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Female infertility